A therapy of beclin 1 injections ameliorates the pathology of synapses and dendrites in PD model mice, and reduces α-synuclein aggregates, indicating that beclin-1 expression mimetics could be a kind of potential drugs for PD treatment [164]. The gene discussed is BECN1; the disease is Parkinson disease.